Liquamox® C broad-spectrum beta-lactam antibiotic with bacterial resistance inhibitor

Liquamox® C

Broad-spectrum beta-lactam antibiotic with bacterial resistance inhibitor

Canines Felines Powder for Oral Suspension

Amoxicillin (as amoxicillin trihydrate) 40 mg, Clavulanic acid (as potassium clavulanate) 5.7 mg, excipients q.s.ad 1 mL

For the treatment of infections caused by susceptible strains (aerobic and anaerobic bacteria): periodontal, skin and soft tissue infections caused by susceptible species of Staphylococcus spp. E. coli, Pasteurella spp. and Streptococcus spp. Suitable for respiratory and urinary tract infections, including those caused by susceptible E. coli species. Treatment of osteomielitis and other bacterial complications sensitive to amoxicillin.

Preparation: shake the bottle to loosen the powder, add water to the bottle mark and shake well. After reconstitution, each mL contains 40 mg of amoxicillin (as trihydrated salt) and 5.7 mg of clavulanic acid (as potassium salt). Let stand for 5 minutes to ensure complete dispersion. Canines: 1 mL/2-3.5 kg every 8-12 hours for 7-28 days. Cats: 1 mL/2-3.5 kg every 8-12 hours for 5-14 days. The reconstituted suspensión must be stored in refrigeration (between 2° C and 8° C) and can be used for up to 7 days.
Bottle x 11 g,

SENASA Registry: SENASA Peru: F.82.32.I.0151

This content is informative reference and should not be considered as prescriptions.

You may also be interested

Amoxigentin®
Amoxigentin®
Broad-spectrum synergistic antibiotic combination
Injectable Suspension
Amoxi-Tabs C®-250
Amoxi-Tabs C®-250
Broad-spectrum antibiotic with bacterial resistance inhibitor
Tablet Oral
Tylamox® WS
Tylamox® WS
Broad-spectrum Macrolide Beta-lactam Synergic-additive Antibiotic Association
Soluble Powder